Medy Tox Inc
KOSDAQ:086900
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medy Tox Inc
KOSDAQ:086900
|
KR |
|
Talisman Mining Ltd
ASX:TLM
|
AU |
|
Ashland Global Holdings Inc
NYSE:ASH
|
US |
Medy Tox Inc
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2009-01-16. The Company’s main product is type A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. Its products are also used in chin plastic surgeries. The firm provides its products under the brand names of Medytoxin, Neurox, Siax, and Neuramis. In addition, the Company develops and sells medical devices such as injectors under the brand names of Neurajet, Neurafen and others. The firm also engages in technology transfer. The firm distributes its products in domestic and overseas markets such as Japan, China, Russia and Europe.
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2009-01-16. The Company’s main product is type A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. Its products are also used in chin plastic surgeries. The firm provides its products under the brand names of Medytoxin, Neurox, Siax, and Neuramis. In addition, the Company develops and sells medical devices such as injectors under the brand names of Neurajet, Neurafen and others. The firm also engages in technology transfer. The firm distributes its products in domestic and overseas markets such as Japan, China, Russia and Europe.
